The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

By R. Leavitt, A. Fauci, D. Bloch, B. Michel, G. G. Hunder, William P. Arend, Leonard H. Calabrese, James F. Fries, J. Lie, R. Lightfoot and 6 more. Arthritis & Rheumatism, 2010

1,959 citations recorded by the source corpus.

Subfields: Physiology, Pulmonary and Respiratory Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/0e4523a470c34125a96292b7d1487f6b67a55df8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Ludvigsson
2. E. Andersson
3. M. Feychting
4. A. Ekbom
5. Jeong‐Lim Kim
6. C. Reuterwall
7. M. Heurgren
8. P. O. Olausson

Citations in the corpus

• Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies (2006, background): “These criteria did not include MPA or ANCA. The ACR criteria for Wegener’s granulomatosis and CSS have a specificity of 92.0% and 99.7%, respectively, with a sensitivity of 88.2% and 85.0%.”
• External review and validation of the Swedish national inpatient register (2011, background): “Wegener’s granulomatosis 68/78 (87) American College of Rheumatology diagnostic criteria [43] Knight [12] 12115591 2002 MR”
• The Five-Factor Score Revisited: Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort (2011, neutral): “Cardiac manifestations 68 (19) 52 (24) 83 (36) 41 (13) 244 (22)”